pharm14520240209161306384EMO_en_20240209161306506.png

過去のプログラムはこちら

罫線.png

罫線1

創薬サイエンス_バナーRGB_w250px.gif

創薬サイエンス

7_10051-2：東京大学.jpg

創薬等先端技術支援基盤プラットフォーム

罫線2

第9回精神薬学会バナー500×200.jpg

第9回日本精神薬学会総会・学術集会

第35回日本医療薬学会年会バナー.jpg

第35回日本医療薬学会年会

罫線3

General information

Overview

Announcements(26)

Timetable

Thu. Mar 27, 2025

Fri. Mar 28, 2025

Sat. Mar 29, 2025

Program & Abstract

Sessions

Search presentations

Selected programs of presentations in English

Download Abstracts PDF

Registration

Registration (Non-presenters under 4th year underg

For Participants and Presenters

Participation Certificate PDF

For Participants

For Presenters

How to use "Confit mobile meeting app"

Exhibition

Companies（Equipment exhibits）

Companies（Medical supplies）

Bibliographic information retrieval system

Companies（Books）

Abstract Submission (Oral/Poster Presentation)

Abstract Submission

header_en_20240313161625152.png

app_icon.png

Profile management

Bookmark

Announcements

Program Type

Login required to view

Password required to view

Presentation Information

Session Details

Enter the password to view the abstracts.<br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Can pharmacy quality indicator evaluations be conducted in the field of oncology?

In 2015, the Ministry of Health, Labor and Welfare introduced the "Pharmacy Vision for Patients," prompting revisions to the Pharmaceutical and Medical Device Act and mandating medication follow-up. This initiative has driven pharmacies to shift from product-focused to person-centered operations, aiming to improve the quality of medical care. However, a robust system for evaluating these outcomes remains underdeveloped.<br>The recent integration of information technology in healthcare has enabled large-scale data analysis, laying the foundation for quantitative and qualitative evaluations of interpersonal services. Now, a decade later, the role of pharmacists in improving healthcare quality through evidence generation and problem-solving has become increasingly critical.<br>To fulfill this role, collaboration among industry, government, and academia, centered around healthcare facilities, is essential. This symposium will explore the future of pharmacy through lectures by experts from various fields, discussing the utilization of real-world data (RWD) in clinical practice. The symposium aims to address how pharmacists can effectively use RWD and the challenges they may face, fostering a multi-faceted and practical dialogue on advancing pharmacy practice.

Shaping the future of pharmacists through data science: insights from industry, government, and academia

The 145th Annual Meeting of the Pharmaceutical Society of Japan (Fukuoka)

Presentation Information

[SS13-3]Can pharmacy quality indicator evaluations be conducted in the field of oncology?

Password required to view